Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-25 @ 4:51 AM
NCT ID:
NCT01212718
Eligibility Criteria:
Inclusion Criteria:
* patients (\>= 18 years) with non-resectable metastasized or recurrent histologically proven CRC with the presence of a reference lesion two-dimensional measurable and accessible for a biopsy
* a performance status WHO 0-2 (Karnofsky \>= 60%)
* an estimated life expectancy of at least 3 months
* written informed consent
Exclusion Criteria:
* patients older than 75 years not fulfilling these criteria
* brain metastases or a secondary cane
* a history of a systemic palliative chemotherapy
* and an adjuvant chemotherapy (within 6 months)
* pregnant or nursing women
* a known allergy toward irinotecanhydroclorid or of any ingredients of Campto or other severe medical
* laboratory and social conditions not allowing chemotherapy and follow-up
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01212718
Study Brief:
Protocol Section:
NCT01212718